Drug Trial Radar · NCT07732309
A Study of ATG-201 in Adult Participants With Autoimmune Diseases
Last checked: Nov 20, 2026Latest source record: Oct 28, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
149
Planned (sponsor's estimate)
Start
Sep 26, 2026
Primary completion
Dec 1, 2028
Study completion Jun 1, 2029
Sponsor
- Lead sponsor
- Antengene Biologics LimitedIndustry
- Sponsor type
- Industry
- First posted
- Jul 28, 2026
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a phase I, open-label study of ATG-201 in participants with autoimmune diseases.
Conditions
- Systemic Lupus Erythematosus
- Systemic Sclerosis (SSc)
- Sjogren's Disease
- Autoimmune Diseases
Interventions
ATG-201Drug
ATG-201 is a recombinant, human IgG1-like TCE that simultaneously binds to human CD3 and CD19.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Safety and TolerabilitySafety and TolerabilityTime frame: 48 weeks
Locations
22 sites in 1 country. Site status is shown where the registry gives one.
The First Affiliated Hospital of Bengbu Medical University
Bengbu, Anhui, China · Not yet recruiting
The First Affiliated Hospital of University of Science and Technology of China
Hefei, Anhui, China · Not yet recruiting
Peking University People's Hospital
Beijing, Beijing Municipality, China · Recruiting
The First Affiliated Hospital of Xiamen University
Xiamen, Fujian, China · Not yet recruiting
Nanfang Hospital of Southern Medical Universit
Guangzhou, Guangdong, China · Not yet recruiting
Sun Yat-sen Memorial Hospital, Sun Yat-sen Universit
Guangzhou, Guangdong, China · Not yet recruiting
The First Affiliated Hospital of Guangzhou University of Chinese Medicine
Guangzhou, Guangdong, China · Not yet recruiting
The First Affiliated Hospital of Sun Yat-sen University
Guangzhou, Guangdong, China · Not yet recruiting
The Third Affiliated Hospital of Sun Yat-sen University
Guangzhou, Guangdong, China · Not yet recruiting
The First Affiliated Hospital of Henan University of Science and Technology
Luoyang, Henan, China · Not yet recruiting
The First Affiliated Hospital of Zhengzhou University
Zhengzhou, Henan, China · Not yet recruiting
Union Hospital Affiliated to Tongji Medical College of Huazhong University of Science and Technology
Wuhan, Hubei, China · Not yet recruiting
Xiangya Hospital of Central South University
Changsha, Hunan, China · Not yet recruiting
Nanjing Drum Tower Hospital Affiliated to Nanjing University Medical School
Nanjing, Jiangsu, China · Not yet recruiting
Nuclear Industry General Hospital
Suzhou, Jiangsu, China · Not yet recruiting
Qilu Hospital of Shandong University
Jinan, Shandong, China · Not yet recruiting
Linyi People's Hospital
Linyi, Shandong, China · Not yet recruiting
Huashan Hospital Affiliated to Fudan University
Shanghai, Shanghai Municipality, China · Not yet recruiting
Renji Hospital, Shanghai Jiao Tong University School of Medicine
Shanghai, Shanghai Municipality, China · Not yet recruiting
The First Hospital of Shanxi Medical University
Taiyuan, Shanxi, China · Not yet recruiting
The Second Affiliated Hospital of Xi'an Jiaotong University
Xi’an, Shanxi, China · Not yet recruiting
The Second Affiliated Hospital of Zhejiang University School of Medicine
Hangzhou, Zhejiang, China · Not yet recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.